In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis.

The new triazole derivative SCH 56592 has been tested in a National Committee for Clinical Laboratory Standards-adapted in vitro susceptibility test, and its activity against 12 isolates of Blastomyces dermatitidis yeast-like forms has been compared with those of amphotericin B, itraconazole, and fl...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Antimicrob Agents Chemother
Päätekijät:	Sugar, A M, Liu, X P
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 1996
Aiheet:	Research Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163319/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8723494/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.5.1314
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!